Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC by Garassino, Marina C., MD, Gadgeel, Shirish, XX, Novello, Silvia, XX, Halmos, Balazs, XX, Felip, Enriqueta, XX, Speranza, Giovanna, XX, Hui, Rina, XX, Garon, Edward B., XX, Horinouchi, Hidehito, XX, Sugawara, Shunichi, XX, Rodriguez-Abreu, Delvys, XX, Reck, Martin, XX, Cristescu, Razvan, XX, Aurora-Garg, Deepti, XX, Loboda, Andrey, XX, Lunceford, Jared, XX, Kobie, Julie, XX, Ayers, Mark, XX, Piperdi, Bilal, XX, Pietanza, M. Catherine, XX, Paz-Ares, Luis, XX

Get full text

Lorlatinib Versus Pemetrexed-Based Chemotherapy in Patients With ALK-rearranged NSCLC Previously Treated With Alectinib by Takeyasu, Yuki, MD, Yoshida, Tatsuya, XX, Masuda, Ken, XX, Matsumoto, Yuji, XX, Shinno, Yuki, XX, Okuma, Yusuke, XX, Goto, Yasushi, XX, Horinouchi, Hidehito, XX, Yamamoto, Noboru, XX, Ohe, Yuichiro, XX

Get full text

Real-World Data Analysis of Pembrolizumab Monotherapy for NSCLC Using Japanese Postmarketing All-Case Surveillance Data by Terai, Hideki, XX, Soejima, Kenzo, MD, PhD, Shimokawa, Asanao, XX, Horinouchi, Hidehito, XX, Shimizu, Junichi, XX, Hase, Tetsunari, XX, Kanemaru, Ryota, XX, Watanabe, Kana, XX, Ninomiya, Kiichiro, XX, Aragane, Naoko, XX, Yanagitani, Noriko, XX, Sakata, Yoshihiko, XX, Seike, Masahiro, XX, Fujimoto, Daichi, XX, Kasajima, Masashi, XX, Kubo, Akihito, XX, Kusumoto, Sojiro, XX, Oyamada, Yoshitaka, XX, Fujiwara, Keiichi, XX, Mori, Masahide, XX, Hashimoto, Midori, XX, Shingyoji, Masato, XX, Kodani, Masahiro, XX, Sakamoto, Jin, XX, Agatsuma, Toshihiko, XX, Kashiwabara, Kosuke, XX, Inomata, Minehiko, XX, Tachihara, Motoko, XX, Tanaka, Kazuhisa, XX, Hayashihara, Kenji, XX, Koyama, Nobuyuki, XX, Matsui, Kaoru, XX, Minato, Koichi, XX, Jingu, Daisuke, XX, Sakashita, Hiroyuki, XX, Hara, Satoshi, XX, Naito, Tomoyuki, XX, Okada, Asuka, XX, Tanahashi, Masayuki, XX, Sato, Yuki, XX, Asano, Koichiro, XX, Takeda, Takayuki, XX, Nakazawa, Kensuke, XX, Harada, Toshiyuki, XX, Shibata, Kazuhiko, XX, Kato, Tatsuo, XX, Miyaoka, Etsuo, XX, Yoshino, Ichiro, XX, Gemma, Akihiko, XX, Mitsudomi, Tetsuya, XX

Get full text

Immunologic Significance of CD80/CD86 or Major Histocompatibility Complex-II Expression in Thymic Epithelial Tumors by Ikeda, Hideki, MD, Nagasaki, Joji, MD, PhD, Shimizu, Daiki, MD, Katsuya, Yuki, MD, PhD, Horinouchi, Hidehito, MD, PhD, Hosomi, Yukio, MD, PhD, Tanji, Etsuko, XX, Iwata, Takekazu, MD, PhD, Itami, Makiko, MD, PhD, Kawazu, Masahito, MD, PhD, Ohe, Yuichiro, MD, PhD, Suzuki, Takuji, MD, PhD, Togashi, Yosuke, MD, PhD

Get full text